Db. Fram et al., LOCALIZED INTRAMURAL DRUG-DELIVERY DURING BALLOON ANGIOPLASTY USING HYDROGEL-COATED BALLOONS AND PRESSURE-AUGMENTED DIFFUSION, Journal of the American College of Cardiology, 23(7), 1994, pp. 1570-1577
Objectives. This study was designed to assess the feasibility of using
hydrogel-coated balloons to deliver biologically active agents to the
blood vessel wall. Background. The local intramural delivery of thera
peutic agents during balloon angioplasty has been proposed as an adjun
ctive technique for preventing early intracoronary thrombosis and late
restenosis. Methods. To assess the efficacy of delivery and depth of
penetration in vitro, local delivery of horseradish peroxidase was per
formed in 40 porcine peripheral arteries, and delivery of fluoresceina
ted heparin was performed in 20 porcine peripheral arteries and 7 huma
n atheromatous arteries. To determine the persistence of these agents
in the vessel wall in vivo, horseradish peroxidase was delivered to 18
porcine peripheral arteries that were harvested at intervals of 45 mi
n to 48 h. Fluoresceinated heparin was delivered to 22 porcine periphe
ral arteries, 14 with the use of a protective sleeve, harvested at int
ervals of 30 s to 24 h. Results. In vitro agent delivery was successfu
l in all specimens. The depth of penetration of horseradish peroxidase
was directly related to both balloon pressure (p < 0.04) and duration
of inflation (p < 0.01), In vivo peroxidase staining was evident at 4
5 and 90 min but not thereafter. With the use of a protective sleeve,
heparin was present in all arteries harvested at 30 s, with marked dis
sipation at 1 and 24 h. Without a sleeve, no fluorescein staining was
detected in any artery. With both agents, delivery occurred consistent
ly over broad regions of the vessel wall that were free of architectur
al disruption. Conclusions. Hydrogel coated balloons can deliver biolo
gically active agents to the vessel wall without gross tissue disrupti
on and may provide an atraumatic method for the local delivery of ther
apeutic agents during balloon angioplasty.